Studies on transcriptional regulation of the mucosal T‐cell integrin αEβ7 (CD103)

Immunology - Tập 103 Số 2 - Trang 146-154 - 2001
Paul Robinson1, Sally J. Green1, Christine Carter1, John Coadwell1, Peter J. Kilshaw1
1The Babraham Institute, Babraham, Cambridge, UK

Tóm tắt

SummaryIntegrin αEβ7 is expressed almost exclusively by mucosal T cells and mucosal dendritic antigen‐presenting cells (APCs) and is thought to be induced locally by transforming growth factor‐β (TGF‐β). In mice, mRNA for the αE subunit was found to be abundant in mucosal T cells but absent from other tissues. Exposure of a T‐cell line to TGF‐β strongly up‐regulated αE mRNA levels within 30 min, and nuclear run‐on experiments established that regulation occurred at the level of transcription. The organization of the human αE gene and a very closely linked novel gene, ELG, was determined. The αE promoter was tested in T cells and fibroblasts and functioned equally well in both cell types and did not confer TGF‐β responsiveness. Regions of the promoter providing enhancer activity and phorbol 12‐myristate 13‐acetate (PMA) responsiveness were identified by deletion studies. DNAse 1 hypersensitivity analysis of 36 kb of the αE gene revealed one hypersensitive site, found only in αE+ cells, located near the transcription start points. These results show that, unlike the situation with other integrins, lineage specificity and cytokine responsiveness of αE transcription are not conferred by the proximal promoter. Specificity may depend on distant control elements that have not yet been identified.

Từ khóa


Tài liệu tham khảo

10.1002/eji.1830170910

10.1016/0165-2478(88)90056-9

10.1136/mp.52.4.203

10.1002/eji.1830201008

10.1073/pnas.89.5.1924

10.1002/eji.1830231246

10.1016/S0171-2985(96)80063-5

Robertson H, 1999, Renal allograft rejection: does CD103 hold the clue to tissue‐specific cytotoxicity?, Immunology, 98, 125

Fujihara T, 1999, Preferential localisation of CD8+ alpha E beta 7+ T cells around acinar epithelial cells with apoptosis in patients with Sjogren's syndrome, J Immunol, 163, 2226, 10.4049/jimmunol.163.4.2226

10.1038/372190a0

10.1002/eji.1830250333

Schon MP, 1999, Mucosal T lymphocyte numbers are selectively reduced in integrin αE (CD103)‐deficient mice, J Immunol, 162, 6641, 10.4049/jimmunol.162.11.6641

10.1002/eji.1830211041

10.1002/eji.1830260427

Shaw SK, 1994, Molecular cloning of the human mucosal lymphocyte integrin αE subunit. Unusual structure and restricted RNA distribution, J Biol Chem, 269, 6016, 10.1016/S0021-9258(17)37563-4

10.1016/1074-7613(94)90070-1

Nueda A, 1993, Characterization of the CD11α (αL, LFA‐1α) integrin gene promoter, J Biol Chem, 268, 19305, 10.1016/S0021-9258(19)36514-7

10.3109/10428199709039028

10.1089/dna.1997.16.929

Zutter MM, 1994, The human α2 integrin gene promoter. Identification of positive and negative regulatory elements important for cell‐type and developmentally restricted gene expression, J Biol Chem, 269, 463, 10.1016/S0021-9258(17)42373-8

Ausubel FM, Current Protocols in Molecular Biology., 10.1002/0471142727

10.1093/emboj/17.11.3091

10.1074/jbc.M001228200

10.1042/bst0270835

10.1006/scdb.1999.0346

10.1146/annurev.immunol.17.1.149

10.1074/jbc.271.25.15279

10.1016/s0169-328x(99)00158-8

10.1385/ENDO:8:3:291

10.3109/15419069309097254

10.1182/blood.V86.1.147.bloodjournal861147

10.1006/bbrc.1996.0790

10.1615/CritRevEukarGeneExpr.v10.i1.20

10.1074/jbc.274.19.13711

10.1074/jbc.274.29.20489

10.1111/j.1365-3083.1995.tb03607.x

Schieferdecker HL, 1990, The HML‐1 antigen of intestinal lymphocytes is an activation antigen, J Immunol, 144, 2541, 10.4049/jimmunol.144.7.2541

10.1016/S0065-2776(00)75003-6

10.1093/emboj/19.8.1745

10.1016/s0955-0674(99)00081-2

10.1165/ajrcmb.15.5.8918367